Scientists hunt for genetic clues to cancer drug side effect
NCT ID NCT02610413
Summary
This study aims to understand why some breast cancer patients develop severe high blood pressure when taking the drug bevacizumab. Researchers will analyze the DNA of about 350 patients who either did or did not experience this side effect. The goal is to find genetic markers that could predict who is at risk, helping doctors manage treatment better in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Eastern Cooperative Oncology Group
RECRUITINGBoston, Massachusetts, 02215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.